Dr. Chandrikha Chandrasekharan, MBBS
Claim this profileUniversity of Iowa/Holden Comprehensive Cancer Center
Area of expertise
Pancreatic Cancer
Chandrikha Chandrasekharan, MBBS has run 7 trials for Pancreatic Cancer. Some of their research focus areas include:
Lung Cancer
Chandrikha Chandrasekharan, MBBS has run 5 trials for Lung Cancer. Some of their research focus areas include:
Affiliated Hospitals
University Of Iowa/Holden Comprehensive Cancer Center
University Of Iowa Healthcare Cancer Services Quad Cities
Clinical Trials Chandrikha Chandrasekharan, MBBS is currently running
Crizotinib
for Non-Small Cell Lung Cancer
This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-small cell lung cancer and an ALK fusion mutation.
Recruiting
2 awards
Phase 3
28 criteria
Ivaltinostat + Capecitabine
for Pancreatic Cancer
This trial tests ivaltinostat with capecitabine in patients with advanced pancreatic cancer who have not worsened after initial treatment. The goal is to find a safe and effective dose and to see if this combination can better control the cancer. Capecitabine is a medication that is converted into another drug in the body, showing better selectivity and tolerability in tumor tissues.
Recruiting
3 awards
Phase 1 & 2
11 criteria
More about Chandrikha Chandrasekharan, MBBS
Clinical Trial Related
6 years of experience running clinical trials · Led 17 trials as a Principal Investigator · 5 Active Clinical Trials
Treatments Chandrikha Chandrasekharan, MBBS has experience with
- Gallium-68 Pentixafor
- Surufatinib
- Tislelizumab
- SY-5609
- Fulvestrant
- Nab-paclitaxel
Breakdown of trials Chandrikha Chandrasekharan, MBBS has run
Pancreatic Cancer
Lung Cancer
Neuroendocrine Tumors
Colorectal Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Chandrikha Chandrasekharan, MBBS specialize in?
Chandrikha Chandrasekharan, MBBS focuses on Pancreatic Cancer and Lung Cancer. In particular, much of their work with Pancreatic Cancer has involved Stage IV patients, or patients who are Stage III.
Is Chandrikha Chandrasekharan, MBBS currently recruiting for clinical trials?
Yes, Chandrikha Chandrasekharan, MBBS is currently recruiting for 5 clinical trials in Iowa City Iowa. If you're interested in participating, you should apply.
Are there any treatments that Chandrikha Chandrasekharan, MBBS has studied deeply?
Yes, Chandrikha Chandrasekharan, MBBS has studied treatments such as Gallium-68 Pentixafor, Surufatinib, Tislelizumab.
What is the best way to schedule an appointment with Chandrikha Chandrasekharan, MBBS?
Apply for one of the trials that Chandrikha Chandrasekharan, MBBS is conducting.
What is the office address of Chandrikha Chandrasekharan, MBBS?
The office of Chandrikha Chandrasekharan, MBBS is located at: University of Iowa/Holden Comprehensive Cancer Center, Iowa City, Iowa 52242 United States. This is the address for their practice at the University of Iowa/Holden Comprehensive Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.